Koyfin Home > Directory > Health Care > LA Jolla Pharma > EV / EBITDA (ntm)

LA Jolla Pharma EV / EBITDA (ntm) Chart (LJPC)

LA Jolla Pharma annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • LA Jolla Pharma Market Cap for the quarter ending March 03, 2018 was $777m a 15.21% increase of 118m year over year
  • LA Jolla Pharma Price / Book for the quarter ending March 03, 2018 was 8.09 a 47.74% increase of 3.86 year over year
  • LA Jolla Pharma Enterprise Value for the quarter ending March 03, 2018 was $692m a 27.38% increase of 190m year over year
View Chart On Koyfin